We are super-excited to announce that we have been selected as a winner of the 2021-2022 Tech Tour South East Europe Program after 2 rounds of intensive and competitive pitching sessions in Athens in May and online in June!
BIOPIX-T was one of the 32 selected companies (out of 150 which applied), seeking bigger seed or series A of investments which were joined by 220+ corporate and VC investors in a super focused event during May in Athens & online sessions during June.
BIOPIX-T was one of the nine companies to receive the badge of Honor for the presentation and its overall proposition.
The recognition helps us push forward with even more enthusiasm and dedication towards our mission and our vision!
BIOPIX DNA TECHNOLOGY P.C. (https://biopix-t.com) was founded in December 2019 in order to commercialize a novel molecular diagnostic method, developed by the founding team, for the detection of nucleic acids at the point-of-care.
The company targets two healthcare-diagnostics related markets through the production of standardized assays for detection and monitoring of Infectious Diseases and Companion Diagnostics